ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL414804
CHEMBL414804
Compound Name OXALIPLATIN
ChEMBL Synonyms SR-96669 | L-OHP | ELOXATIN | RP-54780 | OXALIPLATIN | JM-83
Max Phase 4 (Approved)
Trade Names ELOXATIN | OXALIPLATIN
Molecular Formula C8H12N2O4Pt

Sources

  • British National Formulary
  • DrugMatrix
  • Orange Book
  • PubChem BioAssays
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL414804 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
DNA inhibitor DNA DailyMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
BREAST NEOPLASMSD001943EFO:0000305BREAST CARCINOMA0ClinicalTrials
CARCINOMA, SQUAMOUS CELLD002294EFO:0000707SQUAMOUS CELL CARCINOMA2ClinicalTrials
LYMPHOMA, NON-HODGKIND008228EFO:0005952NON-HODGKINS LYMPHOMA2ClinicalTrials
PANCREATIC NEOPLASMSD010190EFO:0002618PANCREATIC CARCINOMA1ClinicalTrials
NASOPHARYNGEAL NEOPLASMSD009303EFO:0004252NASOPHARYNGEAL NEOPLASM2ClinicalTrials
OVARIAN NEOPLASMSD010051EFO:0001075OVARIAN CARCINOMA2ClinicalTrials
COLORECTAL NEOPLASMSD015179EFO:0000365COLORECTAL ADENOCARCINOMA3ClinicalTrials
ESOPHAGEAL NEOPLASMSD004938EFO:0002916ESOPHAGEAL CARCINOMA2ClinicalTrials
GLIOSARCOMAD018316EFO:1001465GLIOSARCOMA1ClinicalTrials
NEOPLASMSD009369EFO:0000311CANCER2ClinicalTrials
STOMACH NEOPLASMSD013274EFO:0000503GASTRIC ADENOCARCINOMA3ClinicalTrials
STOMACH NEOPLASMSD013274EFO:0000178GASTRIC CARCINOMA3ClinicalTrials
URINARY BLADDER NEOPLASMSD001749EFO:0000292BLADDER CARCINOMA2ClinicalTrials
BILIARY TRACT NEOPLASMSD001661EFO:0003891BILIARY TRACT NEOPLASM3ClinicalTrials
CARCINOMA, HEPATOCELLULARD006528EFO:0000182HEPATOCELLULAR CARCINOMA2ClinicalTrials
HODGKIN DISEASED006689EFO:0000183HODGKINS LYMPHOMA2ClinicalTrials
STOMACH NEOPLASMSD013274EFO:0003897STOMACH NEOPLASM3ClinicalTrials
RECTAL NEOPLASMSD012004EFO:1000657RECTUM CANCER1ClinicalTrials

Clinical Data

ClinicalTrials.gov OXALIPLATIN
The Cochrane Collaboration OXALIPLATIN

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 - ANTINEOPLASTIC AGENTS
L01X - OTHER ANTINEOPLASTIC AGENTS
L01XA - Platinum compounds
L01XA03 - oxaliplatin

ChemSpider ChemSpider Identifier not yet assigned
DailyMed oxaliplatin
PubChem SID: 144206138 SID: 144206182
Wikipedia Oxaliplatin
spacer
spacer